These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4510913)

  • 41. [Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations].
    Rabukhin AE; Alekseeva VM; Ivanova ES; Kubyshkina VF; Kliuchareva EA
    Probl Tuberk; 1970; 48(8):18-22. PubMed ID: 5496733
    [No Abstract]   [Full Text] [Related]  

  • 42. Nontuberculous mycobacterial infections of man.
    Wolinsky E
    Med Clin North Am; 1974 May; 58(3):639-48. PubMed ID: 4132589
    [No Abstract]   [Full Text] [Related]  

  • 43. Mycobacterial infections in patients with HIV: a review of disease and care.
    Hendell M
    Nurse Pract; 1998 Oct; 23(10):75-8, 83. PubMed ID: 9805333
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands.
    van Ingen J; Bendien SA; de Lange WC; Hoefsloot W; Dekhuijzen PN; Boeree MJ; van Soolingen D
    Thorax; 2009 Jun; 64(6):502-6. PubMed ID: 19213773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Experimental study of secondary tuberculostatic preparations in view of the resistance of mycobacteria to the primary drugs].
    Uvarova OA; Zemskova ZS; Stukalova BIa; Afanas'eva IuP
    Farmakol Toksikol; 1967; 30(4):474-7. PubMed ID: 4877410
    [No Abstract]   [Full Text] [Related]  

  • 46. [Criteria of clinical resistance of cycloserine, ethionamide and ethambutol].
    Okamoto K; Watanabe S; Terunuma K
    Kekkaku; 1970 Feb; 45(2):65-72. PubMed ID: 4985702
    [No Abstract]   [Full Text] [Related]  

  • 47. Surgical management of pulmonary tuberculosis due to atypical mycobacteria.
    Hattler BG; Young WG; Sealy WC; Gentry WH; Cox CB
    J Thorac Cardiovasc Surg; 1970 Mar; 59(3):366-71. PubMed ID: 5415082
    [No Abstract]   [Full Text] [Related]  

  • 48. [Pulmonary mycobacteriosis due to Mycobacterium battey with favorable development under medical treatment].
    Constans P; Parrot R; Aubriot G; Morin Y; Bariéty M
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):957-66. PubMed ID: 5402998
    [No Abstract]   [Full Text] [Related]  

  • 49. [Experimental infections caused by atypical mycobacteria. 6. Experimental Mycobacterium fortuitum infection and trial chemotherapy].
    Kuze F; Lee Y; Maekawa N; Suzuki Y
    Kekkaku; 1983 Jul; 58(7):385-93. PubMed ID: 6656072
    [No Abstract]   [Full Text] [Related]  

  • 50. Ethionamide, pyrazinamide and cycloserine in drug resistant cases.
    Narang RK; Singh SK
    Indian J Chest Dis; 1973 Jan; 15(1):16-20. PubMed ID: 4695462
    [No Abstract]   [Full Text] [Related]  

  • 51. The pathogenicity of Mycobacterium fortuitum and Mycobacterium chelonei in man: a report of seven cases.
    Dreisin RB; Scoggin C; Davidson PT
    Tubercle; 1976 Mar; 57(1):49-57. PubMed ID: 941300
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Experiences with antitubercular agents of the second line].
    Zierski M
    Wien Med Wochenschr; 1966 Oct; 116(40):824-7. PubMed ID: 5927179
    [No Abstract]   [Full Text] [Related]  

  • 53. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES; Komarova AA
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract]   [Full Text] [Related]  

  • 54. Pulmonary disease due to Mycobacterium Kansasii. An analysis of some factors affecting prognosis.
    Johanson WG; Nicholson DP
    Am Rev Respir Dis; 1969 Jan; 99(1):73-85. PubMed ID: 5762115
    [No Abstract]   [Full Text] [Related]  

  • 55. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M; Izumi K; Kamima H; Hirose H; Saito M
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract]   [Full Text] [Related]  

  • 56. Treatment of disease caused by nontuberculous mycobacteria.
    Bass JB; Hawkins EL
    Arch Intern Med; 1983 Jul; 143(7):1439-41. PubMed ID: 6870414
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Extrathoracic tuberculosis in Siberia and the Far East].
    Kul'chavenia EV; Brizhatiuk EV; Khomiakov VT
    Probl Tuberk Bolezn Legk; 2005; (6):23-6. PubMed ID: 16078716
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lung disease caused by Mycobacterium avium/Mycobacterium intracellulare. An analysis of Danish patients during the period 1962-1976.
    Engbaek HC; Vergmann B; Bentzon MW
    Eur J Respir Dis; 1981; 62(2):72-83. PubMed ID: 7238667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Triple reserved scheme in the treatment of resistent forms of pulmonary tuberculosis (preliminary results)].
    Rizzo A; Magalhães M; Moura N
    Rev Bras Med; 1969 Sep; 26(9):504-10. PubMed ID: 5381888
    [No Abstract]   [Full Text] [Related]  

  • 60. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.